Siegert W - Search Results

1

High-dose treatment with carboplatin, etoposide, and ifosfamide followed by autologous stem-cell transplantation in relapsed or refractory germ cell cancer: a phase I/II study. The German Testicular Cancer Cooperative Study Group.

Siegert W, Beyer J, Strohscheer I, Baurmann H, Oettle H, Zingsem J, Zimmermann R, Bokemeyer C, Schmoll HJ, Huhn D. Siegert W, et al. J Clin Oncol. 1994 Jun;12(6):1223-31. doi: 10.1200/JCO.1994.12.6.1223. J Clin Oncol. 1994. PMID: 7911158 Clinical Trial.

2

Cutaneous toxicity of high-dose carboplatin, etoposide and ifosfamide followed by autologous stem cell reinfusion.

Beyer J, Grabbe J, Lenz K, Weisbach V, Strohscheer I, Huhn D, Siegert W. Beyer J, et al. Among authors: siegert w. Bone Marrow Transplant. 1992 Dec;10(6):491-4. Bone Marrow Transplant. 1992. PMID: 1362685 Clinical Trial.

3

Treatment intensification in disseminated germ-cell tumors.

Beyer J, Bokemeyer C, Schmoll HJ, Siegert W. Beyer J, et al. Among authors: siegert w. World J Urol. 1994;12(4):207-13. doi: 10.1007/BF00185676. World J Urol. 1994. PMID: 7820143 Review.

4

Impact of preleukapheresis cell counts on collection results and correlation of progenitor-cell dose with engraftment after high-dose chemotherapy in patients with germ cell cancer.

Schwella N, Beyer J, Schwaner I, Heuft HG, Rick O, Huhn D, Serke S, Siegert W. Schwella N, et al. Among authors: siegert w. J Clin Oncol. 1996 Apr;14(4):1114-21. doi: 10.1200/JCO.1996.14.4.1114. J Clin Oncol. 1996. PMID: 8648365

5

High-dose chemotherapy as salvage treatment in germ cell tumors: a multivariate analysis of prognostic variables.

Beyer J, Kramar A, Mandanas R, Linkesch W, Greinix A, Droz JP, Pico JL, Diehl A, Bokemeyer C, Schmoll HJ, Nichols CR, Einhorn LH, Siegert W. Beyer J, et al. Among authors: siegert w. J Clin Oncol. 1996 Oct;14(10):2638-45. doi: 10.1200/JCO.1996.14.10.2638. J Clin Oncol. 1996. PMID: 8874322

6

High-dose chemotherapy and ASCR of patients with relapsed or refractory germ cell tumors: long-term follow-up.

Siegert W, Beyer J. Siegert W, et al. Bone Marrow Transplant. 1996 Sep;18 Suppl 1:S60. Bone Marrow Transplant. 1996. PMID: 8899176 No abstract available.

7

Prognosis after high-dose chemotherapy in patients with germ cell tumors.

Beyer J, Siegert W. Beyer J, et al. Among authors: siegert w. Bone Marrow Transplant. 1996 Sep;18 Suppl 1:S61-2. Bone Marrow Transplant. 1996. PMID: 8899177 No abstract available.

8

Long-term survival of patients with recurrent or refractory germ cell tumors after high dose chemotherapy.

Beyer J, Kingreen D, Krause M, Schleicher J, Schwaner I, Schwella N, Huhn D, Siegert W. Beyer J, et al. Among authors: siegert w. Cancer. 1997 Jan 1;79(1):161-8. Cancer. 1997. PMID: 8988741 Clinical Trial.

9

Nephrotoxicity after high-dose carboplatin, etoposide and ifosfamide in germ-cell tumors: incidence and implications for hematologic recovery and clinical outcome.

Beyer J, Rick O, Weinknecht S, Kingreen D, Lenz K, Siegert W. Beyer J, et al. Among authors: siegert w. Bone Marrow Transplant. 1997 Nov;20(10):813-9. doi: 10.1038/sj.bmt.1700980. Bone Marrow Transplant. 1997. PMID: 9404920 Clinical Trial.

10

High-dose chemotherapy with carboplatin, etoposide and ifosfamide followed by autologous stem cell rescue in patients with relapsed or refractory malignant lymphomas: a phase I/II study.

Kleiner S, Kirsch A, Schwaner I, Kingreen D, Schwella N, Huhn D, Siegert W. Kleiner S, et al. Among authors: siegert w. Bone Marrow Transplant. 1997 Dec;20(11):953-9. doi: 10.1038/sj.bmt.1701002. Bone Marrow Transplant. 1997. PMID: 9422474 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

238 results

Search Page

Filters